Publication | Open Access

Clinical and Immunological Improvementin a Patient Who Received Thalidomide Treatment for Refractory<i>Mycobacterium avium</i>Complex Infection

Thalidomide TreatmentAntibioticsImmunological ImprovementinHealthcare-associated InfectionImmunologyClinical InfectionPatient WhoInfection ControlClinical Infectious DiseaseMedicineClinical MicrobiologyAntimicrobial Resistance